Episode Details

What does it truly mean to live longer—and how can we separate promising longevity science from exaggerated claims? In this episode of the Ageless and Timeless Podcast, Michele Hughes welcomes back longevity researcher and biogerontology scientist Bill Lawrence, PhD, for an evidence-focused exploration of biological aging, healthspan, and peptide bioregulators. Dr. Lawrence explains the important distinctions between lifespan, healthspan, and biological longevity. He also discusses how researchers use biomarkers such as telomere length, epigenetic testing, pace of aging, and organ-specific biological age to evaluate potential longevity interventions. Drawing upon his work with the scientific legacy of Professor Vladimir Khavinson, Dr. Lawrence introduces Khavinson Peptide Bioregulators—short, organ-specific regulatory peptides studied for their potential influence on gene expression, cellular repair, and age-related functional decline. He explains how these compounds differ from popular synthetic peptides and why the two categories may serve very different purposes. The conversation also examines the evidence behind today’s most talked-about longevity interventions. Dr. Lawrence separates approaches that may improve general health or reduce disease risk from those he believes meet a more rigorous standard for influencing biological aging. Michele and Dr. Lawrence Discuss

• The difference between lifespan, healthspan, and biological longevity
• Why Americans may spend so many of their later years managing chronic illness
• The importance of published research and measurable biomarkers
• How telomeres and epigenetic clocks are used to estimate biological aging
• How organ-specific biological age testing can help identify accelerated aging
• The difference between peptide bioregulators and synthetic therapeutic peptides
• Why synthetic peptides may be better suited to short-term or acute needs
• The long-term, regenerative focus of peptide bioregulators
• Professor Vladimir Khavinson’s research into pineal and thymus peptides
• The Hayflick limit and the role of cellular replication in aging
• Research examining peptides, mortality risk, and age-related functional decline
• Studies involving peptide bioregulators and vision-related conditions
• How personalized peptide protocols may be developed using biological-age testing
• Dr. Lawrence’s ongoing biological-age interventional studies

This episode is the first part of an expansive discussion with Dr. Lawrence. A future conversation will continue with peptide bioregulators, biological-age reversal, and the measurable outcomes emerging from his research. About Bill Lawrence, PhD Bill Lawrence, PhD, is a longevity researcher and biogerontology scientist specializing in Khavinson Peptide Bioregulators, biological aging, and epigenetic regulation. His work focuses on translating decades of Eastern European and Russian research involving short regulatory peptides into frameworks accessible to Western clinicians and researchers. Dr. Lawrence is closely associated with the scientific legacy of Vladimir Khavinson, MD, PhD, whose laboratory and clinical studies investigated organ-specific peptide bioregulators and their potential roles in gene expression, tissue repair, and age-related functional decline. Dr. Lawrence’s work centers on mechanistic interpretation, clinical synthesis, and biomarker-based evaluation, particularly through epigenetic aging measurements, telomere biology, and systems-level biomarkers. He currently administers two biological-age interventional clinical studies. Medical Disclaimer – Ageless and Timeless Podcast Ageless and Timeless (the “Show”), along with its host and guests, shares insights and discussions on health, wellness, and longevity for informational and educational purposes only. The Show does not provide medical advice, diagnoses, treatments, cures, or preventa